StonvexLoading…
StonvexStonvexStonvexCore line items from IQ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.90B | $4.00B | $4.49B | $4.20B |
Operating Income | $32.79M | $248.13M | $421.06M | $190.28M |
Net Income | $-29.50M | $104.68M | $271.20M | $-19.75M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $6.68B | $6.27B | $6.28B | $6.68B |
Total Liabilities | $4.77B | $4.44B | $4.56B | $5.76B |
Cash & Equivalents | $622.65M | $483.56M | $624.59M | $1.03B |
Free Cash Flow OCF − CapEx | $1.43M | $278.21M | $466.86M | $-35.50M |
Shares Outstanding | Not available | Not available | Not available | Not available |